212 related articles for article (PubMed ID: 3926881)
1. Activation of resting T lymphocytes by anti-CD3 (T3) antibodies in the absence of monocytes.
Tsoukas CD; Landgraf B; Bentin J; Valentine M; Lotz M; Vaughan JH; Carson DA
J Immunol; 1985 Sep; 135(3):1719-23. PubMed ID: 3926881
[TBL] [Abstract][Full Text] [Related]
2. Activation of T cells by cross-linking an anti-CD3 antibody with a second anti-T cell antibody: mechanism and subset-specific activation.
Walker C; Bettens F; Pichler WJ
Eur J Immunol; 1987 Jun; 17(6):873-80. PubMed ID: 2439351
[TBL] [Abstract][Full Text] [Related]
3. Differences in the stimulating capacity of immobilized anti-CD3 monoclonal antibodies: variable dependence on interleukin-1 as a helper signal for T-cell activation.
Verwilghen J; Baroja ML; Van Vaeck F; Van Damme J; Ceuppens JL
Immunology; 1991 Feb; 72(2):269-76. PubMed ID: 1826671
[TBL] [Abstract][Full Text] [Related]
4. Differential T cell hyporesponsiveness induced by in vivo administration of intact or F(ab')2 fragments of anti-CD3 monoclonal antibody. F(ab')2 fragments induce a selective T helper dysfunction.
Hirsch R; Archibald J; Gress RE
J Immunol; 1991 Oct; 147(7):2088-93. PubMed ID: 1833451
[TBL] [Abstract][Full Text] [Related]
5. Regulation by anti-CD2 monoclonal antibody of the activation of a human T cell clone induced by anti-CD3 or anti-T cell receptor antibodies.
Yssel H; Aubry JP; de Waal Malefijt R; de Vries JE; Spits H
J Immunol; 1987 Nov; 139(9):2850-5. PubMed ID: 2444643
[TBL] [Abstract][Full Text] [Related]
6. Induction of human monocyte IL-1 mRNA and secretion during anti-CD3 mitogenesis requires two distinct T cell-derived signals.
Landis RC; Friedman ML; Fisher RI; Ellis TM
J Immunol; 1991 Jan; 146(1):128-35. PubMed ID: 1824588
[TBL] [Abstract][Full Text] [Related]
7. T cell activation via CD2 [T, gp50] molecules: accessory cells are required to trigger T cell activation via CD2-D66 plus CD2-9.6/T11(1) epitopes.
Brottier P; Boumsell L; Gelin C; Bernard A
J Immunol; 1985 Sep; 135(3):1624-31. PubMed ID: 2410496
[TBL] [Abstract][Full Text] [Related]
8. Antibodies against the CD44 p80, lymphocyte homing receptor molecule augment human peripheral blood T cell activation.
Denning SM; Le PT; Singer KH; Haynes BF
J Immunol; 1990 Jan; 144(1):7-15. PubMed ID: 1967267
[TBL] [Abstract][Full Text] [Related]
9. Cross-linking Fc receptors on monocytes triggers IL-6 production. Role in anti-CD3-induced T cell activation.
Krutmann J; Kirnbauer R; Köck A; Schwarz T; Schöpf E; May LT; Sehgal PB; Luger TA
J Immunol; 1990 Sep; 145(5):1337-42. PubMed ID: 2143517
[TBL] [Abstract][Full Text] [Related]
10. A common pathway for T lymphocyte activation involving both the CD3-Ti complex and CD2 sheep erythrocyte receptor determinants.
Yang SY; Chouaib S; Dupont B
J Immunol; 1986 Aug; 137(4):1097-100. PubMed ID: 2426350
[TBL] [Abstract][Full Text] [Related]
11. A VLA-4 alpha-chain specific monoclonal antibody enhances CD3-induced IL-2/IL-2 receptor-dependent T-cell proliferation.
Udagawa T; McIntyre BW
Lymphokine Cytokine Res; 1992 Oct; 11(5):193-9. PubMed ID: 1467362
[TBL] [Abstract][Full Text] [Related]
12. Different T cell subset stimulation by IgG1 or IgG2a anti-T3 antibodies.
Walker C; Pichler WJ; de Weck AL
Immunobiology; 1986 Jul; 171(4-5):412-24. PubMed ID: 2427438
[TBL] [Abstract][Full Text] [Related]
13. IL-6 is an accessory signal in the alternative CD2-mediated pathway of T cell activation.
Lorré K; Van Damme J; Verwilghen J; Baroja ML; Ceuppens JL
J Immunol; 1990 Jun; 144(12):4681-7. PubMed ID: 1972166
[TBL] [Abstract][Full Text] [Related]
14. Growth factor production and requirements during the proliferative response of human T lymphocytes to anti-CD3 monoclonal antibody.
Granelli-Piperno A; Keane M; Steinman RM
J Immunol; 1989 Jun; 142(12):4138-43. PubMed ID: 2524526
[TBL] [Abstract][Full Text] [Related]
15. Studies on the monocyte dependence of T-cell proliferation induced by monoclonal antibodies directed against regions I and II of the CD2 antigen.
van Lier R; Bloemena E; Brouwer M; Van Heijst J; Weinreich S; Aarden L
Immunology; 1989 Jul; 67(3):333-8. PubMed ID: 2474490
[TBL] [Abstract][Full Text] [Related]
16. Effects of in vivo administration of anti-CD3 monoclonal antibody on T cell function in mice. II. In vivo activation of T cells.
Hirsch R; Gress RE; Pluznik DH; Eckhaus M; Bluestone JA
J Immunol; 1989 Feb; 142(3):737-43. PubMed ID: 2521507
[TBL] [Abstract][Full Text] [Related]
17. Signal delivery by physical interaction and soluble factors from accessory cells in the induction of receptor-mediated T-cell proliferation. Synergistic effect of BSF-2/IL-6 and IL-1.
Kawakami K; Kakimoto K; Shinbori T; Onoue K
Immunology; 1989 Jul; 67(3):314-20. PubMed ID: 2503436
[TBL] [Abstract][Full Text] [Related]
18. Natural killer cells activated by interleukin 2 treatment in vivo respond to interleukin 2 primarily through the p75 receptor and maintain the p55 (TAC) negative phenotype.
Weil-Hillman G; Voss SD; Fisch P; Schell K; Hank JA; Sosman JA; Sugamura K; Sondel PM
Cancer Res; 1990 May; 50(9):2683-91. PubMed ID: 1691679
[TBL] [Abstract][Full Text] [Related]
19. T-cell activation. I. Evidence for a functional linkage between class I MHC antigens and the Tc-Ti complex.
Brams P; Claesson MH
Immunology; 1989 Mar; 66(3):348-53. PubMed ID: 2522906
[TBL] [Abstract][Full Text] [Related]
20. Requirement for delivery of signals by physical interaction and soluble factors from accessory cells in the induction of receptor-mediated T cell proliferation. Effectiveness of IFN-gamma modulation of accessory cells for physical interaction with T cells.
Kawakami K; Yamamoto Y; Kakimoto K; Onoue K
J Immunol; 1989 Mar; 142(6):1818-25. PubMed ID: 2493498
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
